| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/DME.13137 |
| P698 | PubMed publication ID | 27087031 |
| P50 | author | Ankit Mangla | Q57038911 |
| P2093 | author name string | S Khurana | |
| N Agarwal | |||
| J J Jiang | |||
| G J Kim | |||
| R Catchatourian | |||
| P2860 | cites work | Molecular basis for insulin fibril assembly | Q24657505 |
| Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration | Q33611211 | ||
| The mechanism of enhanced insulin amyloid fibril formation by NaCl is better explained by a conformational change model | Q34087988 | ||
| Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes | Q37603286 | ||
| Islet amyloid polypeptide, islet amyloid, and diabetes mellitus | Q37899668 | ||
| Amyloid fibrillation and cytotoxicity of insulin are inhibited by the amphiphilic surfactants | Q39736568 | ||
| The systemic amyloidoses | Q41596634 | ||
| Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism | Q43607506 | ||
| Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report | Q46478865 | ||
| Impaired absorption of insulin aspart from lipohypertrophic injection sites | Q46618649 | ||
| Insulin-derived amyloidosis and poor glycemic control: a case series. | Q50729325 | ||
| P433 | issue | 12 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | e32-e35 | |
| P577 | publication date | 2016-04-18 | |
| P1433 | published in | Diabetic Medicine | Q15758639 |
| P1476 | title | Localized insulin amyloidosis with use of concentrated insulin: a potential complication | |
| P478 | volume | 33 |
| Q47623946 | Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons. | cites work | P2860 |
Search more.